Skip to main content
. 2016 Nov;47:218.e1–218.e9. doi: 10.1016/j.neurobiolaging.2016.07.024

Table 2.

Demographic and clinical features of sIBM patients carrying variants in SQSTM1 and VCP genes

Features Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7
Sex F M M F M F M
Ethnicity Caucasian Caucasian Indian subcontinent Caucasian Caucasian Caucasian Caucasian
Age at onset 45 50 71 57 85 74 48
Family history
Finger flexor weakness + + + + + + +
Weakness of KE > HF + + UNK
Weakness of FF > SA + + + + UNK + +
Weakness of WF > WE + + + UNK
PDB
ALS
FTD
Parkinson's disease
Elevated CK (×ULN) + (≤15) + (≤15) + (≤15) N/A + (≤15)
Neurophysiological investigation Myopathic Myopathic Myopathic N/A UNK N/A N/A
MRC 2010 sIBM diagnostic category PAD PAD PAD CLD PO PO PO

Key: ALS, amyotrophic lateral sclerosis; CK, creatine kinase; CLD, clinically defined; F, female; FF, finger flexion; FTD, frontotemporal dementia; HF, hip flexion; KE, knee extension; M, male; N/A, not available; PAD, pathologically defined; PDB, Paget disease of bone; PO, possible; SA, shoulder abduction; sIBM, sporadic inclusion body myositis; SQSTM1, sequestosome 1; ULN, upper limit of normal; UNK, unknown; VCP, valosin-containing protein; WE, wrist extension; WF, wrist flexion.